InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2025: USD 28.30 M

InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 28.30 M for the Trailing 12 Months (TTM) ending June 30, 2025, a 52.81% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 18.52 M, a 45.11% change year over year.
  • InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 12.76 M, a 12.89% change year over year.
  • InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 11.30 M, a 18.38% change year over year.
  • InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 9.55 M, a 25.62% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue